Is FDA Most Science-Based and Less patient Centric Now that Gottlieb is in Charge?
admin
September 27, 2017
Last October, FDA caved in to patients lobbying on behalf of Sarepta's Duchenne drug Exondys 51 despite the fact that there was little s...
Is FDA Most Science-Based and Less patient Centric Now that Gottlieb is in Charge?
Reviewed by admin
on
September 27, 2017
Rating: